(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of USP2 mRNA] CTD PMID:31150632 (2,4,5-trichlorophenoxy)acetic acid decreases expression ISO RGD:735358 6480464 2 more ... CTD PMID:18579281 1,2-dichloroethane decreases expression ISO RGD:735358 6480464 ethylene dichloride results in decreased expression of USP2 mRNA CTD PMID:28189721 , PMID:28960355 1,2-dimethylhydrazine decreases expression ISO RGD:735358 6480464 1, 2-Dimethylhydrazine results in decreased expression of USP2 mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions ISO RGD:735358 6480464 Folic Acid inhibits the reaction [1, 2-Dimethylhydrazine results in decreased expression of USP2 mRNA] CTD PMID:22206623 1-benzylpiperazine decreases expression EXP 6480464 N-benzylpiperazine results in decreased expression of USP2 mRNA CTD PMID:26821219 17alpha-ethynylestradiol affects expression ISO RGD:735358 6480464 Ethinyl Estradiol affects the expression of USP2 mRNA CTD PMID:17555576 17alpha-ethynylestradiol multiple interactions ISO RGD:735358 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of USP2 mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression ISO RGD:735358 6480464 Ethinyl Estradiol results in increased expression of USP2 mRNA CTD PMID:17942748 17beta-estradiol multiple interactions ISO RGD:731337 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of USP2 mRNA CTD PMID:30165855 17beta-estradiol affects expression EXP 6480464 Estradiol affects the expression of USP2 mRNA CTD PMID:32145629 1H-pyrazole decreases expression ISO RGD:735358 6480464 pyrazole results in decreased expression of USP2 mRNA CTD PMID:17945193 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:735358 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 2,2',4,4'-Tetrabromodiphenyl ether decreases expression EXP 6480464 2 more ... CTD PMID:20056577 , PMID:27291303 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO RGD:735358 6480464 2 more ... CTD PMID:30294300 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:735358 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:17942748 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of USP2 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:735358 6480464 Tetrachlorodibenzodioxin affects the expression of USP2 mRNA CTD PMID:21570461 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of USP2 mRNA CTD PMID:19490992 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of USP2 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:735358 6480464 Tetrachlorodibenzodioxin results in increased expression of USP2 mRNA CTD PMID:19465110 , PMID:19770486 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of USP2 mRNA CTD PMID:21346803 2-hydroxypropanoic acid decreases expression ISO RGD:731337 6480464 Lactic Acid results in decreased expression of USP2 mRNA CTD PMID:30851411 3,3',4,4'-tetrachlorobiphenyl multiple interactions ISO RGD:735358 6480464 3 more ... CTD PMID:19467301 3,3',5,5'-tetrabromobisphenol A decreases expression EXP 6480464 tetrabromobisphenol A results in decreased expression of USP2 mRNA CTD PMID:28300664 3-hydroxyisovaleric acid increases expression EXP 6480464 beta-hydroxyisovaleric acid results in increased expression of USP2 mRNA CTD PMID:24124592 4,4'-sulfonyldiphenol decreases expression ISO RGD:735358 6480464 bis(4-hydroxyphenyl)sulfone results in decreased expression of USP2 mRNA CTD PMID:33297965 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of USP2 mRNA CTD PMID:24780913 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of USP2 mRNA CTD PMID:28959563 Actein decreases expression EXP 6480464 actein results in decreased expression of USP2 protein CTD PMID:29969672 aflatoxin B1 affects expression ISO RGD:731337 6480464 Aflatoxin B1 affects the expression of USP2 protein CTD PMID:20106945 aflatoxin B1 decreases methylation ISO RGD:731337 6480464 Aflatoxin B1 results in decreased methylation of USP2 gene CTD PMID:27153756 aflatoxin B1 increases expression ISO RGD:731337 6480464 Aflatoxin B1 results in increased expression of USP2 mRNA CTD PMID:21641981 aflatoxin B1 decreases expression ISO RGD:735358 6480464 Aflatoxin B1 results in decreased expression of USP2 mRNA CTD PMID:19770486 aldrin decreases expression ISO RGD:735358 6480464 Aldrin results in decreased expression of USP2 mRNA CTD PMID:18579281 all-trans-retinoic acid decreases expression ISO RGD:731337 6480464 Tretinoin results in decreased expression of USP2 mRNA CTD PMID:33167477 amiodarone increases expression ISO RGD:731337 6480464 Amiodarone results in increased expression of USP2 mRNA CTD PMID:19774075 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of USP2 mRNA CTD PMID:16483693 amphotericin B increases expression ISO RGD:731337 6480464 Amphotericin B analog results in increased expression of USP2 mRNA CTD PMID:28534445 antirheumatic drug decreases expression ISO RGD:731337 6480464 Antirheumatic Agents results in decreased expression of USP2 mRNA CTD PMID:24449571 aristolochic acid A increases expression ISO RGD:731337 6480464 aristolochic acid I results in increased expression of USP2 mRNA CTD PMID:33212167 arsenite(3-) increases methylation ISO RGD:731337 6480464 arsenite results in increased methylation of USP2 promoter CTD PMID:23974009 atrazine increases expression ISO RGD:731337 6480464 Atrazine results in increased expression of USP2 mRNA CTD PMID:22378314 azoxystrobin multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of USP2 mRNA CTD PMID:33854195 benzo[a]pyrene increases expression ISO RGD:731337 6480464 Benzo(a)pyrene results in increased expression of USP2 mRNA CTD PMID:20106945 benzo[a]pyrene affects methylation ISO RGD:731337 6480464 Benzo(a)pyrene affects the methylation of USP2 5' UTR, Benzo(a)pyrene affects the methylation of USP2 promoter CTD PMID:27901495 benzo[a]pyrene increases methylation ISO RGD:731337 6480464 Benzo(a)pyrene results in increased methylation of USP2 3' UTR, Benzo(a)pyrene results in increased methylation of USP2 exon CTD PMID:27901495 benzo[a]pyrene multiple interactions ISO RGD:735358 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of USP2 mRNA CTD PMID:27858113 benzo[a]pyrene increases expression ISO RGD:735358 6480464 Benzo(a)pyrene results in increased expression of USP2 mRNA CTD PMID:19770486 more ... benzo[b]fluoranthene increases expression ISO RGD:735358 6480464 benzo(b)fluoranthene results in increased expression of USP2 mRNA CTD PMID:26377693 benzo[b]fluoranthene multiple interactions ISO RGD:735358 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of USP2 mRNA CTD PMID:27858113 Benzo[k]fluoranthene increases expression ISO RGD:735358 6480464 benzo(k)fluoranthene results in increased expression of USP2 mRNA CTD PMID:26377693 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:735358 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 bisphenol A decreases expression ISO RGD:735358 6480464 bisphenol A results in decreased expression of USP2 mRNA CTD PMID:26063408 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of USP2 mRNA CTD PMID:35192832 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of USP2 mRNA CTD PMID:32145629 bisphenol A decreases expression ISO RGD:731337 6480464 bisphenol A results in decreased expression of USP2 mRNA CTD PMID:31715268 bisphenol A multiple interactions ISO RGD:735358 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of USP2 mRNA CTD PMID:25181051 bromobenzene increases expression EXP 6480464 bromobenzene results in increased expression of USP2 mRNA CTD PMID:32479839 C60 fullerene affects expression EXP 6480464 fullerene C60 affects the expression of USP2 mRNA CTD PMID:19167457 cadmium dichloride decreases expression ISO RGD:735358 6480464 Cadmium Chloride results in decreased expression of USP2 mRNA CTD PMID:20061341 calcium atom multiple interactions ISO RGD:735358 6480464 [[USP2 gene mutant form results in increased expression of NHERF4 protein] which results in increased activity of TRPV6 protein] which results in increased uptake of Calcium CTD PMID:26756164 calcium(0) multiple interactions ISO RGD:735358 6480464 [[USP2 gene mutant form results in increased expression of NHERF4 protein] which results in increased activity of TRPV6 protein] which results in increased uptake of Calcium CTD PMID:26756164 cannabidiol decreases expression ISO RGD:735358 6480464 Cannabidiol results in decreased expression of USP2 mRNA CTD PMID:21542829 , PMID:30307084 carbon nanotube decreases expression ISO RGD:735358 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:25620056 carbon nanotube increases expression ISO RGD:735358 6480464 Nanotubes, Carbon analog results in increased expression of USP2 mRNA CTD PMID:25620056 CGP 52608 multiple interactions ISO RGD:731337 6480464 CGP 52608 promotes the reaction [RORA protein binds to USP2 gene] CTD PMID:28238834 chloroprene increases expression ISO RGD:735358 6480464 Chloroprene results in increased expression of USP2 mRNA CTD PMID:23125180 chloroquine increases expression ISO RGD:735358 6480464 Chloroquine results in increased expression of USP2 mRNA CTD PMID:28134560 chloroquine multiple interactions ISO RGD:735358 6480464 Chloroquine promotes the reaction [lipopolysaccharide more ... CTD PMID:28134560 chlorpyrifos increases expression ISO RGD:735358 6480464 Chlorpyrifos results in increased expression of USP2 mRNA CTD PMID:20350560 chlorpyrifos multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of USP2 mRNA CTD PMID:33854195 choline multiple interactions ISO RGD:735358 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in increased expression of USP2 mRNA, [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of USP2 mRNA CTD PMID:20938992 , PMID:33549593 chrysene increases expression ISO RGD:735358 6480464 chrysene results in increased expression of USP2 mRNA CTD PMID:26377693 chrysene multiple interactions ISO RGD:735358 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of USP2 mRNA CTD PMID:27858113 ciguatoxin CTX1B affects expression ISO RGD:735358 6480464 Ciguatoxins affects the expression of USP2 mRNA CTD PMID:18353800 cisplatin decreases expression ISO RGD:731337 6480464 Cisplatin results in decreased expression of USP2 mRNA CTD PMID:27392435 cisplatin multiple interactions ISO RGD:731337 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of USP2 mRNA CTD PMID:27392435 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of USP2 mRNA CTD PMID:24386269 copper atom decreases expression ISO RGD:735358 6480464 Copper results in decreased expression of USP2 mRNA CTD PMID:17205981 copper(0) decreases expression ISO RGD:735358 6480464 Copper results in decreased expression of USP2 mRNA CTD PMID:17205981 copper(II) sulfate decreases expression ISO RGD:735358 6480464 Copper Sulfate results in decreased expression of USP2 mRNA CTD PMID:18579281 cyanocob(III)alamin multiple interactions ISO RGD:735358 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in increased expression of USP2 mRNA CTD PMID:33549593 cyclosporin A decreases expression ISO RGD:731337 6480464 Cyclosporine results in decreased expression of USP2 mRNA CTD PMID:20106945 decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of USP2 mRNA CTD PMID:23640034 dexamethasone increases expression ISO RGD:735358 6480464 Dexamethasone results in increased expression of USP2 mRNA CTD PMID:22733784 dibenz[a,h]anthracene increases expression ISO RGD:735358 6480464 1 more ... CTD PMID:26377693 dichloroacetic acid decreases expression ISO RGD:735358 6480464 Dichloroacetic Acid results in decreased expression of USP2 mRNA CTD PMID:28962523 dicrotophos increases expression ISO RGD:731337 6480464 dicrotophos results in increased expression of USP2 mRNA CTD PMID:28302478 diethyl maleate decreases expression EXP 6480464 diethyl maleate results in decreased expression of USP2 mRNA CTD PMID:21161181 dimethylarsinic acid increases expression EXP 6480464 Cacodylic Acid results in increased expression of USP2 mRNA CTD PMID:17720352 dorsomorphin multiple interactions ISO RGD:731337 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of USP2 mRNA CTD PMID:27188386 doxorubicin decreases expression ISO RGD:731337 6480464 Doxorubicin results in decreased expression of USP2 mRNA CTD PMID:29803840 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of USP2 mRNA CTD PMID:29391264 entinostat increases expression ISO RGD:731337 6480464 entinostat results in increased expression of USP2 mRNA CTD PMID:27188386 epoxiconazole affects expression ISO RGD:735358 6480464 epoxiconazole affects the expression of USP2 mRNA CTD PMID:35436446 ethanol multiple interactions ISO RGD:735358 6480464 Ethanol affects the expression of and affects the splicing of USP2 mRNA CTD PMID:30319688 folic acid multiple interactions ISO RGD:735358 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in increased expression of USP2 mRNA more ... CTD PMID:20938992 more ... gallic acid decreases expression ISO RGD:731337 6480464 Gallic Acid results in decreased expression of USP2 mRNA CTD PMID:34408198 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of USP2 mRNA CTD PMID:33387578 glycine betaine multiple interactions ISO RGD:735358 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in increased expression of USP2 mRNA CTD PMID:33549593 glyphosate multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of USP2 mRNA CTD PMID:33854195 graphene oxide increases expression ISO RGD:735358 6480464 graphene oxide results in increased expression of USP2 mRNA CTD PMID:33227293 hypochlorous acid decreases expression ISO RGD:735358 6480464 Hypochlorous Acid results in decreased expression of USP2 mRNA CTD PMID:19376150 imidacloprid multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of USP2 mRNA CTD PMID:33854195 inulin multiple interactions ISO RGD:735358 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of USP2 mRNA CTD PMID:36331819 isoprenaline multiple interactions EXP 6480464 [Isoproterenol co-treated with POSTN protein] results in decreased expression of USP2 mRNA CTD PMID:30303030 isotretinoin decreases expression ISO RGD:731337 6480464 Isotretinoin results in decreased expression of USP2 mRNA CTD PMID:20436886 ketamine increases expression EXP 6480464 Ketamine results in increased expression of USP2 mRNA CTD PMID:20080153 L-methionine multiple interactions ISO RGD:735358 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in increased expression of USP2 mRNA, [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of USP2 mRNA CTD PMID:20938992 , PMID:33549593 lead(0) affects expression ISO RGD:731337 6480464 Lead affects the expression of USP2 mRNA CTD PMID:28903495 leflunomide increases expression EXP 6480464 leflunomide results in increased expression of USP2 mRNA CTD PMID:24136188 levofloxacin increases expression EXP 6480464 Levofloxacin results in increased expression of USP2 mRNA CTD PMID:24136188 lipopolysaccharide decreases expression ISO RGD:731337 6480464 Lipopolysaccharides results in decreased expression of USP2 mRNA CTD PMID:35811015 lipopolysaccharide multiple interactions ISO RGD:731337 6480464 [S-(1 more ... CTD PMID:35811015 malathion increases expression ISO RGD:731337 6480464 Malathion results in increased expression of USP2 mRNA CTD PMID:37047231 mercury dichloride increases expression EXP 6480464 Mercuric Chloride results in increased expression of USP2 mRNA CTD PMID:16507785 metacetamol decreases expression ISO RGD:735358 6480464 3-hydroxyacetanilide results in decreased expression of USP2 mRNA CTD PMID:18544908 methotrexate affects expression ISO RGD:735358 6480464 Methotrexate affects the expression of USP2 mRNA CTD PMID:18502557 methoxychlor affects methylation EXP 6480464 Methoxychlor affects the methylation of USP2 gene CTD PMID:35440735 Muraglitazar increases expression EXP 6480464 muraglitazar results in increased expression of USP2 mRNA CTD PMID:21515302 N-nitrosodiethylamine decreases expression EXP 6480464 Diethylnitrosamine results in decreased expression of USP2 mRNA CTD PMID:19638242 nickel atom decreases expression ISO RGD:731337 6480464 Nickel results in decreased expression of USP2 mRNA CTD PMID:24768652 nickel sulfate decreases expression ISO RGD:731337 6480464 nickel sulfate results in decreased expression of USP2 mRNA CTD PMID:22714537 paracetamol decreases expression ISO RGD:735358 6480464 Acetaminophen results in decreased expression of USP2 mRNA CTD PMID:18544908 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of USP2 mRNA CTD PMID:33387578 paracetamol affects expression ISO RGD:735358 6480464 Acetaminophen affects the expression of USP2 mRNA CTD PMID:17562736 paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of USP2 mRNA CTD PMID:32680482 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:735358 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of USP2 mRNA, [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of USP2 mRNA CTD PMID:36331819 perfluorooctanoic acid increases expression ISO RGD:735358 6480464 perfluorooctanoic acid results in increased expression of USP2 mRNA CTD PMID:30711707 phenformin decreases expression EXP 6480464 Phenformin results in decreased expression of USP2 mRNA CTD PMID:31324951 phenobarbital multiple interactions ISO RGD:735358 6480464 NR1I3 protein affects the reaction [Phenobarbital results in increased expression of USP2 mRNA] CTD PMID:19482888 phenobarbital decreases expression ISO RGD:735358 6480464 Phenobarbital results in decreased expression of USP2 mRNA CTD PMID:23091169 phenobarbital increases expression ISO RGD:735358 6480464 Phenobarbital results in increased expression of USP2 mRNA CTD PMID:19270015 , PMID:19482888 phenylmercury acetate decreases expression ISO RGD:731337 6480464 Phenylmercuric Acetate results in decreased expression of USP2 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:731337 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of USP2 mRNA CTD PMID:27188386 pirinixic acid affects expression ISO RGD:735358 6480464 pirinixic acid affects the expression of USP2 mRNA CTD PMID:17950772 , PMID:18445702 pirinixic acid decreases expression ISO RGD:735358 6480464 pirinixic acid results in decreased expression of USP2 mRNA CTD PMID:23811191 pirinixic acid multiple interactions ISO RGD:735358 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of USP2 mRNA, [PPARA protein affects the susceptibility to pirinixic acid] which affects the expression of USP2 mRNA CTD PMID:19710929 , PMID:21318169 potassium dichromate increases expression ISO RGD:735358 6480464 Potassium Dichromate results in increased expression of USP2 mRNA CTD PMID:23608068 quercetin decreases expression ISO RGD:731337 6480464 Quercetin results in decreased expression of USP2 mRNA CTD PMID:20596804 quercetin multiple interactions ISO RGD:735358 6480464 [Quercetin co-treated with Dietary Fats] affects the expression of USP2 mRNA CTD PMID:23359794 rac-lactic acid decreases expression ISO RGD:731337 6480464 Lactic Acid results in decreased expression of USP2 mRNA CTD PMID:30851411 resveratrol increases expression EXP 6480464 resveratrol results in increased expression of USP2 mRNA CTD PMID:25905778 ritodrine increases expression ISO RGD:735358 6480464 Ritodrine results in increased expression of USP2 mRNA CTD PMID:23370008 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:731337 6480464 [S-(1 more ... CTD PMID:35811015 SB 431542 multiple interactions ISO RGD:731337 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of USP2 mRNA CTD PMID:27188386 serpentine asbestos decreases expression ISO RGD:731337 6480464 Asbestos, Serpentine results in decreased expression of USP2 mRNA CTD PMID:24160326 sevoflurane affects expression EXP 6480464 sevoflurane affects the expression of USP2 mRNA CTD PMID:15967596 sodium arsenate decreases expression ISO RGD:735358 6480464 sodium arsenate results in decreased expression of USP2 mRNA CTD PMID:21795629 sodium arsenate increases expression ISO RGD:735358 6480464 sodium arsenate results in increased expression of USP2 mRNA CTD PMID:21795629 sodium arsenite decreases expression ISO RGD:731337 6480464 sodium arsenite results in decreased expression of USP2 mRNA CTD PMID:22714537 sodium arsenite decreases expression ISO RGD:735358 6480464 sodium arsenite results in decreased expression of USP2 mRNA CTD PMID:36209798 sodium arsenite affects methylation ISO RGD:731337 6480464 sodium arsenite affects the methylation of USP2 gene CTD PMID:28589171 sodium arsenite increases expression ISO RGD:731337 6480464 sodium arsenite results in increased expression of USP2 mRNA CTD PMID:17879257 streptozocin increases expression EXP 6480464 Streptozocin results in increased expression of USP2 mRNA CTD PMID:25905778 succimer multiple interactions ISO RGD:735358 6480464 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of USP2 mRNA, [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of USP2 mRNA CTD PMID:21641980 , PMID:26378955 sulforaphane decreases expression ISO RGD:731337 6480464 sulforaphane results in decreased expression of USP2 mRNA CTD PMID:26833863 sulforaphane multiple interactions ISO RGD:735358 6480464 [NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of USP2 mRNA CTD PMID:30529165 sunitinib decreases expression ISO RGD:731337 6480464 Sunitinib results in decreased expression of USP2 mRNA CTD PMID:31533062 tamoxifen increases expression ISO RGD:735358 6480464 Tamoxifen results in increased expression of USP2 mRNA CTD PMID:25123088 tamoxifen affects expression ISO RGD:735358 6480464 Tamoxifen affects the expression of USP2 mRNA CTD PMID:17555576 , PMID:20937368 testosterone enanthate affects expression ISO RGD:731337 6480464 testosterone enanthate affects the expression of USP2 mRNA CTD PMID:17440010 tetrachloromethane decreases expression ISO RGD:735358 6480464 Carbon Tetrachloride results in decreased expression of USP2 mRNA CTD PMID:27339419 , PMID:31919559 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of USP2 mRNA] CTD PMID:31150632 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of USP2 mRNA CTD PMID:31150632 tetraphene increases expression ISO RGD:735358 6480464 benz(a)anthracene results in increased expression of USP2 mRNA CTD PMID:26377693 tetraphene multiple interactions ISO RGD:735358 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of USP2 mRNA CTD PMID:27858113 thiabendazole multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of USP2 mRNA CTD PMID:33854195 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of USP2 mRNA CTD PMID:34492290 tributylstannane increases expression ISO RGD:735358 6480464 tributyltin results in increased expression of USP2 mRNA CTD PMID:31939706 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of USP2 mRNA CTD PMID:33387578 triclosan decreases expression ISO RGD:731337 6480464 Triclosan results in decreased expression of USP2 mRNA CTD PMID:30510588 triphenyl phosphate affects expression EXP 6480464 triphenyl phosphate affects the expression of USP2 mRNA CTD PMID:30589522 troglitazone increases expression EXP 6480464 troglitazone results in increased expression of USP2 mRNA CTD PMID:21515302 trovafloxacin decreases expression ISO RGD:735358 6480464 trovafloxacin results in decreased expression of USP2 mRNA CTD PMID:35537566 valdecoxib decreases expression EXP 6480464 valdecoxib results in decreased expression of USP2 mRNA CTD PMID:24136188 valproic acid affects expression ISO RGD:735358 6480464 Valproic Acid affects the expression of USP2 mRNA CTD PMID:17963808 valproic acid increases expression ISO RGD:735358 6480464 Valproic Acid results in increased expression of USP2 mRNA CTD PMID:21427059 valproic acid increases expression ISO RGD:731337 6480464 Valproic Acid results in increased expression of USP2 mRNA CTD PMID:23179753 , PMID:29154799 valproic acid decreases expression ISO RGD:731337 6480464 Valproic Acid results in decreased expression of USP2 mRNA CTD PMID:24935251 zinc atom multiple interactions ISO RGD:735358 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in increased expression of USP2 mRNA CTD PMID:33549593 zinc(0) multiple interactions ISO RGD:735358 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in increased expression of USP2 mRNA CTD PMID:33549593